Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹4,178 Cr revenue.
COGS 50.4%, employees 10.0%.
“peak potential of these already confirmed molecules, as I explained earlier, will take at least three years.”
“We have delivered an 8% increase in that big overall.”
“EBITDA was maintained at 13%, same as quarter two.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 8.7%▲ | 7.6% |
| ROCE | 10.8%▼ | 10.9% |
| Net Margin | 6.2%▲ | 5.1% |
| EBITDA Margin | 13.4%▲ | 12.1% |
| Debt To Equity | 0.27x▲ | 0.20x |
| Rev Growth 3yr | -5.4%▼ | 5.9% |
| EPS Growth 3yr | -19.2%▼ | -9.4% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹4,261 Cr +2.0% | ₹4,178 Cr +1.0% | ₹4,136 Cr -13.3% | ₹4,773 Cr -3.6% | ₹4,949 Cr +623.5% | ₹684 Cr |
| Other Income | ₹40 Cr +5.3% | ₹38 Cr +7.1% | ₹35 Cr +5.8% | ₹33 Cr +6.0% | ₹31 Cr | ₹3 Cr |
| Total Income | ₹4,301 Cr +2.0% | ₹4,215 Cr +1.1% | ₹4,171 Cr -13.2% | ₹4,806 Cr -3.5% | ₹4,981 Cr +625.3% | ₹687 Cr |
| COGS | ₹2,209 Cr +4.8% | ₹2,107 Cr -1.6% | ₹2,143 Cr -17.0% | ₹2,582 Cr -7.6% | ₹2,794 Cr +655.3% | ₹370 Cr |
| ₹3,928 Cr +1.4% | ₹3,872 Cr -0.8% | ₹3,904 Cr -10.7% | ₹4,369 Cr +2.3% | ₹4,272 Cr +616.3% | ₹596 Cr | |
| Profit Before Tax | ₹360 Cr +4.7% | ₹344 Cr +28.4% | ₹268 Cr -38.7% | ₹437 Cr -38.4% | ₹709 Cr +816.1% | ₹77 Cr |
| Exceptional Items | (₹13 Cr) | ₹0.00 Cr | ₹0.00 Cr +100.0% | (₹0.04 Cr) | ₹0.00 Cr +100.0% | (₹13 Cr) |
| ₹94 Cr +2.0% | ₹92 Cr +9.1% | ₹85 Cr -34.4% | ₹129 Cr -44.4% | ₹232 Cr +908.4% | ₹23 Cr | |
| Net Profit | ₹266 Cr +5.7% | ₹251 Cr +37.3% | ₹183 Cr -40.5% | ₹308 Cr -35.5% | ₹477 Cr +776.9% | ₹54 Cr |
| Profit (Owners) | ₹266 Cr +5.7% | ₹251 Cr +37.3% | ₹183 Cr -40.5% | ₹308 Cr -35.5% | ₹477 Cr +776.9% | ₹54 Cr |
| Other Comprehensive Income | ₹24 Cr | ₹2 Cr -49.3% | ₹4 Cr +46.3% | ₹2 Cr -97.5% | ₹96 Cr | ₹5 Cr |
| EPS | ₹16.66 | ₹15.77 | ₹11.48 | ₹19.31 | ₹29.93 | ₹3.41 |
| Diluted Shares | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Profit Or Loss Of Associates | (₹0.13 Cr) -550.0% | (₹0.02 Cr) ↓ Decline | ₹0.02 Cr | ₹0.00 Cr +100.0% | (₹0.05 Cr) | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Jubilant Ingrevia Limited has informed the Exchange about Copy of Newspaper Publication
Jubilant Ingrevia Limited has informed the Exchange about Investor Presentation
Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "Press release and presentation on the financials and operational performance of the Company fo...
Jubilant Ingrevia Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2026.
Jubilant Ingrevia Limited has informed the Exchange regarding Appointment of M/s J.K. Kabra & Co. as Cost Auditors of the company for FY 2026-27
Jubilant Ingrevia Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026.
Jubilant Ingrevia Limited has informed the Exchange that Board of Directors at its meeting held on May 26, 2026, recommended Final Dividend of Rs. 2.5 per equity share.
Jubilant Ingrevia Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Jubilant Ingrevia Limited has informed the Exchange about Action(s) taken or orders passed
Jubilant Ingrevia Limited has informed the Exchange about Action(s) taken or orders passed
Significant increase in volume has been observed in Jubilant Ingrevia Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the mark...
Hari Shanker Bhartia Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeove...
Jubilant Ingrevia Limited has informed the Exchange about change in Management
Jubilant Ingrevia Limited has informed the Exchange about Copy of Newspaper Publication
Jubilant Ingrevia Limited has informed the Exchange about Action(s) taken or orders passed